12 Health Care Stocks Moving In Wednesday's After-Market Session
Transcode Therapeutics Inc RNAZ
$4.56
▼ -13.14%
($-0.69)
⬇️ Below Yest. Low
🎈 Low Float
🗓️ Earnings Next Week
Open
$5.13
Prev Close
$5.25
Day Range
$4.47 – $5.37
52W Range
$3.82 – $20.99
Market Cap
$4.83M
Beta
1.24
EPS (TTM)
$-45.07
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-04-28 |
| Shares Out. | 1,060,000 |
| Website | transcodetherapeutics.com/ ↗ |
| Phone | 13026587581 |
| Employees | 12 |
| Net Income | -$17.8M |
| Free Cash Flow | -$21.4M |
| Total Assets | $157.2M |
| Total Liabilities | $12.6M |
| Equity | $1.3M |
About Transcode Therapeutics Inc
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.
Transcode Therapeutics Inc is a publicly traded company under the ticker symbol RNAZ on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
7 analysts (2025-06-01)